| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 08/01/2006 | CA2189456C Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 07/27/2006 | WO2006078753A1 N-substituted heterocyclic sulfonamides |
| 07/27/2006 | WO2006078621A2 2-phenoxy-n- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders |
| 07/27/2006 | WO2006078283A2 Quinoxaline inhibitors of hedgehog signalling |
| 07/27/2006 | WO2006077851A1 Quinolone derivative and salt thereof |
| 07/27/2006 | WO2006077846A1 Therapeutic agent for attention-deficit hyperactivity disorder |
| 07/27/2006 | WO2006077365A1 Indoles useful in the treatment of inflammation |
| 07/27/2006 | WO2006076802A1 An improved process for the preparation of mycophenolate mofetil |
| 07/27/2006 | WO2006066173A3 Novel mch receptor antagonists |
| 07/27/2006 | WO2006060712A9 Potassium salt of an hiv integrase inhibitor |
| 07/27/2006 | WO2005061466A9 Novel phenylalanine derivative |
| 07/27/2006 | US20060167269 Compounds and methods for the inhibition of compounds cruzi |
| 07/27/2006 | US20060167261 e.g. N-(4-Chloro-3-trifluoro methyl phenyl)-2-[3-(4-pyridinyloxy)phenyl amino]-acetamide; serine/threonine kinase inhibitor; anticarcinogenic, antiproliferative, antidiabetic agent; autoimmune diseases; atherosclerosis, arthritis, Crohn's disease, retinopaty |
| 07/27/2006 | US20060167251 CCR9 inhibitors and methods of use thereof |
| 07/27/2006 | US20060167249 Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses |
| 07/27/2006 | US20060167248 Substituted morpholine and thiomorpholine derivatives |
| 07/27/2006 | US20060167247 Urea inhibitors of MAP kinases |
| 07/27/2006 | US20060167066 Pyrrolidine inhibitors of IAP |
| 07/27/2006 | US20060167063 Process for the manufacture of isradipine |
| 07/27/2006 | US20060167053 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance |
| 07/27/2006 | US20060167052 Piperidine derivative, process for producing the same, and use |
| 07/27/2006 | US20060167036 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
| 07/27/2006 | US20060167008 Substituted 1,4,-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/27/2006 | US20060167000 veterinary medicine; neurodegenerative diseases; Alzheimers's Disease |
| 07/27/2006 | US20060166991 Pyridine carboxamide derivatives and their use as pesticides |
| 07/27/2006 | US20060166988 Novel compounds |
| 07/27/2006 | US20060166986 Novel stereoselective synthesis of benzimidazole sulfoxides |
| 07/27/2006 | US20060166985 Pyrrolydin-2-one derivatives as inhibitors of thrombin and factor xa |
| 07/27/2006 | US20060166983 Indole derivatives as ppar modulators |
| 07/27/2006 | US20060166982 Isotopically labelly indlinone derivatives and process for their preparation |
| 07/27/2006 | US20060166963 Processes for producing 4-aminoquinazolines |
| 07/27/2006 | US20060166962 2-{4-[(4-{bis[4-(trifluoromethyl)phenyl]methyl}1-oxypiperazinyl)methyl]phenoxy}pyrimidine; insecticide, controlling tobacco budworm, wheat, corn, soybeans, potatoes, and cotton; for soil-borne insects, such as termites and white grubs |
| 07/27/2006 | US20060166866 Cell adhesion inhibitors |
| 07/27/2006 | CA2595205A1 Heteroaryl substituted piperazinyl-pyridine analogues |
| 07/27/2006 | CA2595173A1 N-substituted heterocyclic sulfonamides |
| 07/27/2006 | CA2594773A1 Indoles useful in the treatment of inflammation |
| 07/27/2006 | CA2593166A1 Mitotic kinesin inhibitors |
| 07/26/2006 | EP1682534A2 Pyrimidin-4-one compounds, compositions, and methods |
| 07/26/2006 | EP1682529A2 Methods for synthesizing quinolinone compounds |
| 07/26/2006 | EP1682524A1 Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 07/26/2006 | EP1682523A1 Morpholine derivatives as norepinephrine reuptake inhibitors |
| 07/26/2006 | EP1682520A1 Amide derivatives |
| 07/26/2006 | EP1682519A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors |
| 07/26/2006 | EP1682516A2 Immobilized n-substituted tricyclic 3-aminopyrazoles for the identification of biomolecular targets |
| 07/26/2006 | EP1682150A2 Compositions and methods for inducing cell dedifferentiation |
| 07/26/2006 | EP1682140A2 Methods of use of thrombin receptor antagonists |
| 07/26/2006 | EP1682138A2 Heterocyclic inhibitors of mek and methods of use thereof |
| 07/26/2006 | EP1682136A1 Therapeutic compounds and uses thereof |
| 07/26/2006 | EP1682126A1 Substituted benzazoles and use thereof as inhibitors of raf kinase |
| 07/26/2006 | EP1549713B1 Synergistic uv absorber combination |
| 07/26/2006 | EP1534705B1 Process for preparing zolmitriptan compounds |
| 07/26/2006 | CN1809917A Assembly for bonding a semiconductor die to substrate with oxazoline derivative bearing an electron donor or acceptor functional group |
| 07/26/2006 | CN1809561A Phenylacetamides and their use as glucokinase modulators |
| 07/26/2006 | CN1809553A Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases |
| 07/26/2006 | CN1809540A Inhibitors of Akt activity |
| 07/26/2006 | CN1809538A Cis-2,4,5-triaryl-imidazolines |
| 07/26/2006 | CN1809536A Inhibitors of Akt activity |
| 07/26/2006 | CN1809531A Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators |
| 07/26/2006 | CN1809360A 4-anilino-quinazoline derivatives as antiproliferative agents |
| 07/26/2006 | CN1809354A Akt活性抑制剂 Akt activity inhibitor |
| 07/26/2006 | CN1809346A Preparation of pyrrolidine-1,2-dicarboxanilide derivatives for use as factor XA and VIIA inhibiting antithrombotic agents, comprises reacting pyrrolidine-2-carboxylic acid with phenyl isocyanate then |
| 07/26/2006 | CN1266140C Process for preparing oxazolines from tetrahydrofurans |
| 07/26/2006 | CN1266138C Gyrase imhibitors and uses thereof |
| 07/26/2006 | CN1266118C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides |
| 07/25/2006 | US7081538 Substituted isoxazolines and their use as antibacterial agents |
| 07/25/2006 | US7081536 Complexes; used for catalyst |
| 07/25/2006 | US7081470 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 07/25/2006 | US7081466 anticarcinogenic agents with improved efficacy against multidrug resistant tumors; improved oral bioavailability and side effect reduction |
| 07/25/2006 | US7081461 Quinazoline compounds and pharmaceutical compositions containing them |
| 07/25/2006 | US7081460 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders |
| 07/25/2006 | US7081457 Contraceptives; hormone replacement therapy |
| 07/25/2006 | US7081454 Anticancer agents |
| 07/25/2006 | CA2161138C Oxidation products of cephalomannine |
| 07/25/2006 | CA2159603C Quinolines as type iv phosphodiesterase inhibitors |
| 07/20/2006 | WO2006076726A1 Synthesis of sodium narcistatin and related compounds |
| 07/20/2006 | WO2006076706A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity |
| 07/20/2006 | WO2006076529A1 Indole derivatives for treating viral infections |
| 07/20/2006 | WO2006075619A1 2-(cyclic aminocarbonyl)indoline derivative and medicinal composition containing the same |
| 07/20/2006 | WO2006074940A2 Macrocyclic compounds and compositions useful as bace inhibitors |
| 07/20/2006 | WO2006074796A1 Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof |
| 07/20/2006 | WO2006059234A3 Bicyclic amides as kinase inhibitors |
| 07/20/2006 | WO2006056877A3 Diazepine oxazolidinones as antibacterial agents |
| 07/20/2006 | WO2006026532A3 Methods of treatment of amyloidosis using substituted ethanolcyclicamine aspartyl protease inhibitors |
| 07/20/2006 | WO2006020277A3 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 07/20/2006 | WO2006015060A3 Isoindoline compounds and methods of their use |
| 07/20/2006 | WO2005121130A3 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 07/20/2006 | US20060161005 For therapy of immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection |
| 07/20/2006 | US20060160886 Chemical compounds |
| 07/20/2006 | US20060160885 Chemical compounds |
| 07/20/2006 | US20060160880 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRI |
| 07/20/2006 | US20060160851 Substituted piperidine carbamates |
| 07/20/2006 | US20060160832 Nitrogen-containing aromatic derivatives |
| 07/20/2006 | US20060160818 Ocular hypotensive agent |
| 07/20/2006 | US20060160813 For therapy of bronchitis, allergic bronchitis, bronchial asthma, emphysema, COPD and allergic rhinitis |
| 07/20/2006 | US20060160807 mitogen-activated protein (MAP) kinase inhibitor; antiproliferative, anticarcinogenic agent; autoimmune disorders; |
| 07/20/2006 | US20060160804 Novel pyridazine derivatives and medicines containing the same as effective ingredients |
| 07/20/2006 | US20060160803 Cinnamide and hydrocinnamide derivatives with kinase inhibitory activity |
| 07/20/2006 | US20060160802 Antibiotics; e.g N-Hydroxy-N-{cis-4-methyl-1-[N'-(4-trifluoromethyl-pyrimidin-2-yl)-hydrazinocarbonyl]-cyclohexylmethyl}-formamide; N-Hydroxy-N-{cis-4-methyl-1-[N'-(4-methyl-pyrimidin-2-yl)-hydrazinocarbonyl]-cyclohexylmethyl}-formamide |
| 07/20/2006 | US20060160801 Pyrimidinone derivaties as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes |
| 07/20/2006 | US20060160800 Morpholino-2-[6-(2-Ethoxy-phenyl)-pyridin-3-yl]-benzyl)-acetamide compound; as anti-proliferative agents, for treating mammals |